The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
about
The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitisEnhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis modelComplement receptor 1 expression on mouse erythrocytes mediates clearance of Streptococcus pneumoniae by immune adherenceSerum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae.Role of complement in host defense against pneumococcal otitis mediaEffect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis.Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.Streptococcus pneumoniae.Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivoProtection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis.Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsoninsThe efficacy of pneumococcal capsular polysaccharide-specific antibodies to serotype 3 Streptococcus pneumoniae requires macrophages.Mouse dendritic cells pulsed with capsular polysaccharide induce resistance to lethal pneumococcal challenge: roles of T cells and B cellsRegions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection modelType-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4.The role of host and microbial factors in the pathogenesis of pneumococcal bacteraemia arising from a single bacterial cell bottleneck.RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies.Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance.Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancerEffects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathwaySpecies-specific interaction of Streptococcus pneumoniae with human complement factor H.Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages.Animal models of Streptococcus pneumoniae diseaseImpaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus.Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.Pneumolysin-induced complement depletion during experimental pneumococcal bacteremiaPspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.Utilization of cholera toxin B as a mucosal adjuvant elicits antibody-mediated protection against S. pneumoniae infection in mice.Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.Bacterial infections and cancer
P2860
Q28386753-31D1AFCE-0544-4102-B33B-38F97DD66221Q28749838-3D0A984C-2A7C-4C61-80FC-FCA1D53C7D90Q30433651-6CC75DAB-D8C4-4E16-BCD8-1B38844D1CFAQ33298405-0D5D1E46-7231-4B82-A734-0000F30D63AAQ33399371-C6ACE9F5-D04D-4F6E-B4FD-05031693230DQ33552889-E9CEAEC0-A4CA-4B20-BA7A-4851C2E2FA7DQ33557154-CC8A13FD-4777-4BC5-8480-1FA5DE3C14D5Q33734675-CFE72940-6835-4BC0-A4C5-583B7D9387DCQ33825652-2B6F6DCD-74A3-45F1-8740-E5BB0B43FB90Q33946852-481B4B7D-12EC-4D26-BB24-5B0D25058DD2Q34004029-35C9F975-37C8-43CE-B769-6B7EE9333197Q34238386-21B9A36C-752C-41E5-8ECC-F553DF1D2DB3Q34314279-5744A982-AA17-4EC5-A359-91593644DC5DQ34713678-21B7227A-C9C0-4DC1-8DA5-CDCC435AE9A7Q34720274-EC55750C-284B-470F-87F1-F51243F1D48FQ34784957-166C2C6A-C10D-41FB-B421-A26770993082Q35108576-2FD4FCAD-8EC5-4480-9B2D-99D8C3A53C4BQ35126697-6A7BCB66-0F25-475F-B53E-9029DEC7C2A3Q35665417-ADF3AB5D-11F9-42E7-882F-076336079066Q35689073-181EE568-F363-4062-B6AD-04A629AE44A2Q35783918-D6D74A64-CD3E-45E1-BDB5-487155898CCCQ36057882-3C5D1381-352C-4E64-985F-894D3A0CE77CQ36228991-0FDBDB0F-DF3A-43B0-9DAA-3D866F335CEDQ36313963-A4B8177A-3F74-4FEF-B8B6-246443DB5695Q36362263-BB6714E9-C40C-400A-B866-57047A76247DQ36804267-63CCA94E-979A-47C2-8D04-32C03DABCC32Q36984721-1966A180-B659-477E-ABF4-898F4FCD6C66Q37033022-981A55CA-8178-4DB8-964A-7BA5B749F583Q37293669-8FDD5051-FBB9-4088-9E08-5BB06DD96306Q37638069-F26889B0-281D-43C4-882D-535582A61E3BQ39164566-3CD9FB6B-725C-4D95-BD15-FDF716F87D8FQ39510800-DC3D9BE2-0D6E-4A80-8EC9-EC5AA68AA876Q39511742-F1FBEB7E-E17F-44A8-A9E0-EEE43960346FQ39520316-A17D2B60-6051-46BC-A830-4E322FECE06DQ40014811-FE6EAA86-BE9E-422D-AE8B-41F98BE133B8Q40056277-780274AA-25FB-46CC-BEDB-332BF170EFA7Q40277871-84F3DDC7-A7EF-4780-9467-3D8AF26C01A1Q40387059-039609D5-68C1-4E08-BE25-9A0CF24B7C04Q57802480-012AB4B7-C886-4C7D-82CF-0BBC6E9DEFA3
P2860
The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
The role of antibody and compl ...... umococci from the bloodstream.
@en
type
label
The role of antibody and compl ...... umococci from the bloodstream.
@en
prefLabel
The role of antibody and compl ...... umococci from the bloodstream.
@en
P2093
P1476
The role of antibody and compl ...... umococci from the bloodstream.
@en
P2093
P304
P478
P577
1983-09-01T00:00:00Z